𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticentriole antibody in a patient with progressive systemic sclerosis

✍ Scribed by Thomas G. Osborn; Jan S. Ryerse; Nancy E. Bauer; Jesse M. Urhahn; Dana Blair; Terry L. Moore


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
491 KB
Volume
29
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Colonic telangiectasias in a patient wit
✍ Murray Baron; Herbert Srolovitz πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 479 KB πŸ‘ 2 views

Although telangiectasias are most commonly found in the skin of progressive systemic sclerosis (PSS) patients, they have also been noted in the gastrointestinal tract (1-7). To our knowledge, telangiectasias in the colon have been described in only 2 PSS patients (5,6). We describe a patient with PS

Focal stent collapse in a patient with s
✍ Di Francesco, Lucia ;Finci, Leo ;Reimers, Bernhard ;Di Mario, Carlo ;Colombo, An πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 269 KB πŸ‘ 2 views

We report a patient with systemic sclerosis having implantation of a 35 mm beStent with immediate success but developing angina at follow-up. A focal stent collapse with focal hyperplasia in and outside the stent was documented by ultrasound after 2 mos. A 14mm Palmaz-Schatz stent was successfully d

Clinical subsets, skin thickness progres
✍ Achini Perera; Noreen Fertig; Mary Lucas; Tatiana S. Rodriguez-Reyna; Paul Hu; V πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 129 KB πŸ‘ 2 views

## Abstract ## Objective To describe the clinical and laboratory features and natural history of the disease in systemic sclerosis (SSc; scleroderma) patients with anti–topoisomerase I (anti–topo I) antibody who have different skin thickness progression rates (STPRs). ## Methods SSc patients (n